secwatch.observer — SEC 8-K summary
======================================

Issuer:     Processa Pharmaceuticals, Inc. (PCSA)
CIK:        0001533743
Form:       8-K
Filed at:   2023-11-15T23:59:59+00:00
Accession:  0001493152-23-041422
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Processa Pharma shareholders approve reverse stock split at ratio up to 1:30
----------------------------------------------------------------------------

- Shareholders approved reverse stock split at ratio between 1:5 and 1:30, board to set exact ratio.
- Votes: 13,895,377 for, 1,341,351 against, 21,455 abstain; 62% quorum of outstanding shares.
- Reverse split must be executed by March 18, 2024, at board's discretion.
- Adjournment proposal also approved but not needed since main proposal passed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533743/000149315223041422/0001493152-23-041422-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533743/000149315223041422/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-041422

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer